Edition:
United States

Profile: Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

1.32USD
22 Sep 2017
Change (% chg)

$0.00 (+0.01%)
Prev Close
$1.32
Open
$1.32
Day's High
$1.35
Day's Low
$1.30
Volume
18,730
Avg. Vol
25,413
52-wk High
$2.46
52-wk Low
$1.11

Acasti Pharma Inc is a Canada-based biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega 3 fatty acids (OM3s) derived from krill oil. OM3s has clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia (HTG). The Company's drug candidate is CaPre, an OM3 phospholipid, which is being developed for the treatment of severe hypertriglyceridemia, a condition characterized by abnormally high levels of triglycerides in the bloodstream (over 500 mg/dL) (severe hypertriglyceridemia or severe HTG).

Company Address

Acasti Pharma Inc

545 Prom du Centropolis Suite 10
LAVAL   QC   H7T 0A3
P: +1450.6872262
F: +1450.6862505

Company Web Links